MichaelC.RowbothamMD
Neurology • San Francisco, CAProfessor, Department of Neurology, UCSF School of Medicine
Are you Dr. Rowbotham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 70 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1701 Divisadero St
San Francisco, CA 94115Phone+1 415-885-7899Fax+1 415-885-7855
Summary
- Dr. Michael Rowbotham, MD is a board certified neurologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with California Pacific Medical Center and UCSF Medical Center.
Education & Training
University of California (San Francisco)Residency, Neurology, 1986 - 1988
Boston University Medical CenterResidency, Neurology, 1984 - 1986- University of California San Francisco School of MedicineClass of 1979
Certifications & Licensure
CA State Medical License 1981 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Levetiracetam for Treatment of Pain Associated With Fibromyalgia Start of enrollment: 2004 Mar 01
- Naltrexone Effects on Alcohol Intake Start of enrollment: 2005 Feb 01
- Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine Start of enrollment: 2005 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Greater recalled pain and movement-evoked pain are associated with longer 400-meter walk and repeat stair climb time: the Study of Muscle, Mobility and Aging.Theresa Mau, Haley N Barnes, Corey B Simon, Megan Hetherington-Rauth, Scott R Bauer
Medrxiv. 2024-10-21 - 1 citationsMethods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement.David Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, Robert H Dworkin, Dennis C Turk
Pain. 2024-10-01 - 3 citationsPatient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerations.Simon Haroutounian, Katherine J Holzer, Robert D Kerns, Christin Veasley, Robert H Dworkin
Pain. 2024-05-01
Press Mentions
Opioid Tolerance, Hyperalgesia Increase Following Stable DosingFebruary 19th, 2020
CPMC Research Institute Scientific Director Receives Top Accolades from the American Academy of NeurologyApril 14th, 2016
Making Inroads in Fight Against Shingles PainFebruary 15th, 2000- Join now to see all
Grant Support
- Chronic Neuropathic Pain Mechanisms And ManagementNational Institute Of Neurological Disorders And Stroke2000–2004
- Pain &Neural Dysfunction From Acute Herpes ZosterNational Institute Of Neurological Disorders And Stroke2000–2002
- Opioid Responsivity/ Analgesic Tolerance In Chronic PainNational Institute Of Neurological Disorders And Stroke2000–2002
- Mechanisms Of Pain And AnalgesiaNational Institute Of Neurological Disorders And Stroke1996–1999
- Opioid Analgesia And Tolerance DevelopmentNational Institute On Drug Abuse1997–1998
